Displaying items by tag: department of medicine

Kirklin has been involved with the American Heart Association in various capacities for more than 20 years.
Published in Addiction, a new paper lays out some of the factors that lead policymakers to look for easy answers to complex problems related to opioid addiction.
The five-year funding award will support the Southern All of Us Network, part of the All of Us Research Program, a nationwide research program to transform how research is conducted to advance individualized prevention, treatment and care for people of all backgrounds.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.
A diabetes drug suggests potential therapy for idiopathic pulmonary fibrosis, based on research with human lung fibroblasts and a mouse model of lung fibrosis.
By using an injected biomarker, researchers are able to have a more accurate reading of kidney function in a clinical setting in half the time it used to take.
Two Novel Research grants from the Lupus Research Alliance boost the study of this complex disease.
Cardiovascular physicians at UAB are providing new services for cancer patients and survivors who develop heart complications during and after treatment.
The UAB hematology nursing staff pulled out all the stops to help a patient and her partner celebrate their love for each other while in the hospital.
Lisa Willett, M.D., was elected as president-elect of the Association of Program Directors in Internal Medicine.
Medicare and Medicaid beneficiaries with end-stage heart failure seeking OHT and LVAD implantation will be drastically affected if the proposed cuts are implemented, according to UAB research.
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients.
Page 26 of 36